Zabaleta A - Search Results

1

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection.

Zabaleta A, D'Avola D, Echeverria I, Llopiz D, Silva L, Villanueva L, Riezu-Boj JI, Larrea E, Pereboev A, Lasarte JJ, Rodriguez-Lago I, Iñarrairaegui M, Sangro B, Prieto J, Sarobe P. Zabaleta A, et al. Mol Ther Methods Clin Dev. 2015 Mar 11;2:15006. doi: 10.1038/mtm.2015.6. eCollection 2015. Mol Ther Methods Clin Dev. 2015. PMID: 26029717 Free PMC article.

2

Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.

Sarobe P, Lasarte JJ, Zabaleta A, Arribillaga L, Arina A, Melero I, Borrás-Cuesta F, Prieto J. Sarobe P, et al. Among authors: zabaleta a. J Virol. 2003 Oct;77(20):10862-71. doi: 10.1128/jvi.77.20.10862-10871.2003. J Virol. 2003. PMID: 14512536 Free PMC article.

3

Engineered promiscuous T helper peptides for the induction of immune responses.

Ruiz M, Llopiz D, Zabaleta A, Lasarte JJ, Borrás-Cuesta F, Sarobe P. Ruiz M, et al. Among authors: zabaleta a. Mol Immunol. 2007 Mar;44(9):2205-12. doi: 10.1016/j.molimm.2006.11.001. Epub 2006 Dec 8. Mol Immunol. 2007. PMID: 17157914 Free article.

4

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.

Zabaleta A, Arribillaga L, Llopiz D, Dotor J, Lasarte JJ, Prieto J, Borrás-Cuesta F, Esteban JI, Quer J, Vayreda F, Sarobe P. Zabaleta A, et al. Antiviral Res. 2007 Apr;74(1):25-35. doi: 10.1016/j.antiviral.2007.01.001. Epub 2007 Jan 22. Antiviral Res. 2007. PMID: 17275104 Free article.

5

Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects.

Llopiz D, Dotor J, Zabaleta A, Lasarte JJ, Prieto J, Borrás-Cuesta F, Sarobe P. Llopiz D, et al. Among authors: zabaleta a. Cancer Immunol Immunother. 2008 Jan;57(1):19-29. doi: 10.1007/s00262-007-0346-8. Epub 2007 Jun 13. Cancer Immunol Immunother. 2008. PMID: 17564702 Free article.

6

Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.

Zabaleta A, Llopiz D, Arribillaga L, Silva L, Riezu-Boj JI, Lasarte JJ, Borrás-Cuesta F, Prieto J, Sarobe P. Zabaleta A, et al. Mol Ther. 2008 Jan;16(1):210-7. doi: 10.1038/sj.mt.6300333. Epub 2007 Oct 9. Mol Ther. 2008. PMID: 17923840 Free article.

7

Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).

Echeverría I, Zabaleta A, Silva L, Díaz-Valdés N, Riezu-Boj JI, Lasarte JJ, Borrás-Cuesta F, Civeira MP, Prieto J, Sarobe P. Echeverría I, et al. Among authors: zabaleta a. J Viral Hepat. 2008 Nov;15(11):782-9. doi: 10.1111/j.1365-2893.2008.01020.x. Epub 2008 Jul 10. J Viral Hepat. 2008. PMID: 18637068

8

Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.

Echeverria I, Pereboev A, Silva L, Zabaleta A, Riezu-Boj JI, Bes M, Cubero M, Borras-Cuesta F, Lasarte JJ, Esteban JI, Prieto J, Sarobe P. Echeverria I, et al. Among authors: zabaleta a. Hepatology. 2011 Jul;54(1):28-37. doi: 10.1002/hep.24325. Epub 2011 May 14. Hepatology. 2011. PMID: 21452282 Free article.

9

Helper cell-independent antitumor activity of potent CD8⁺ T cell epitope peptide vaccines is dependent upon CD40L.

Llopiz D, Huarte E, Ruiz M, Bezunartea J, Belsúe V, Zabaleta A, Lasarte JJ, Prieto J, Borrás-Cuesta F, Sarobe P. Llopiz D, et al. Among authors: zabaleta a. Oncoimmunology. 2013 Dec 1;2(12):e27009. doi: 10.4161/onci.27009. Epub 2013 Dec 5. Oncoimmunology. 2013. PMID: 24498563 Free PMC article.

10

Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.

Zabaleta A, Riezu-Boj JI, Larrea E, Villanueva L, Lasarte JJ, Guruceaga E, Fisicaro P, Ezzikouri S, Missale G, Ferrari C, Benjelloun S, Prieto J, Sarobe P. Zabaleta A, et al. J Med Virol. 2016 May;88(5):843-51. doi: 10.1002/jmv.24399. Epub 2015 Oct 19. J Med Virol. 2016. PMID: 26447929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page